AveXis

Biotechnology company

About

Corporation
Organization
Thing
AveXis is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in 2015 by Brian Kaspar around a discovery of a novel method of treating spinal muscular atrophy using gene therapy.
AveXis
Definition
AveXis is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in 2015 by Brian Kaspar around a discovery of a novel method of treating spinal muscular atrophy using gene therapy.
AveXis
AveXis
AveXis is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in 2015 by Brian Kaspar around a discovery of a novel method of treating spinal muscular atrophy using gene therapy.

Mentions

"We saw just remarkable results for these kids," says David Lennon, president of AveXis,Inc., of Bannockburn, Ill., the company that developed Zolgensma. The company is owned by drug giant Novartis. (AveXis connected NPR with the Weisgarber family.)

See also: